http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114085907-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97f412a22f8f8f1195a7281ec378ed21 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N27-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate | 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ab50bcce80c630f197c38dbb156a40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73af2779b21b76e2480227070b410314 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c73f1aa7452e36006b7ca815aa6358b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baa2412991184164a8d585c794c6463f |
| publicationDate | 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114085907-A |
| titleOfInvention | Method for determining pancreatic cancer progression by MSI2-Numb combined with metabolic molecules |
| abstract | A method for determining pancreatic cancer progression by MSI2-Numb combined with metabolic molecules belongs to the technical field of detection, and comprises tumor tissue resection stage detection and blood prognosis stage detection. The tumor tissue resection stage detection comprises tumor tissue cell pretreatment, tumor tissue Musashi2 determination, tumor tissue Numb determination, blood metabolism molecule determination and judgment; the detection of the blood prognosis stage comprises the detection of blood Musashi2, the detection of blood Numb, the detection of blood metabolism molecules and prognosis; the invention provides a method for determining pancreatic cancer progression by combining MSI2-Numb with metabolic molecules, which can be used for screening pancreatic cancer progression by determining expression of Musashi2 and Numb in pancreatic cancer tissues and combining blood detection, can objectively evaluate clinical tumor progression, drug resistance and poor prognosis, is beneficial to drawing up an optimal treatment scheme, and has detection precision 20% higher than that of the existing detection method. |
| priorityDate | 2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.